Search Results - "Tal-Singer, Ruth"

Treatment decisions: insights from people with asthma or COPD and their healthcare providers on disease and treatment decisions.

Authors: Tal-Singer, Ruth Román-Rodríguez, Miguel McMullan, Ilona et al.

Source: Patient Preference & Adherence. Jun2025, Vol. 19, p1583-1591. 9p.

Disease Impact and Perception of Biologics in Adults with Type 2 Inflammation Respiratory Disease: International Survey Results.

Authors: Tal-Singer, Ruth Willard, Kristen S Luttmann, Mark A et al.

Source: Patient Preference & Adherence. Apr2025, Vol. 18, p1159-1170. 12p.

Patient and Caregiver Perceptions on Education and Treatment Needs in Atopic Dermatitis from an International Survey.

Authors: Willard, Kristen Novak, Špela Lio, Peter A. et al.

Source: Dermatology & Therapy. Jan2026, Vol. 16 Issue 1, p391-403. 13p.

CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial.

Authors: Lazaar, Aili L. Miller, Bruce E. Donald, Alison C. et al.

Source: Respiratory Research. 6/12/2020, Vol. 21 Issue 1, p1-10. 10p. 1 Diagram, 5 Charts, 1 Graph.

Perspectives on Treatment Decisions, Preferences, and Adherence and Long-Term Management in Asthma and COPD: A Qualitative Analysis of Patient, Caregiver, and Healthcare Provider Insights.

Authors: Román-Rodríguez, Miguel McMullan, Ilona Warner, Michelle et al.

Source: Patient Preference & Adherence. Nov2024, Vol. 18, p2295-2306. 12p.

Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort.

Authors: Rønnow, Sarah R. Langholm, Lasse L. Karsdal, Morten A. et al.

Source: Respiratory Research. 7/30/2020, Vol. 21 Issue 1, p1-6. 6p. 1 Diagram, 1 Chart, 2 Graphs.

The sputum microbiome is distinct between COPD and health, independent of smoking history.

Authors: Haldar, Koirobi George, Leena Wang, Zhang et al.

Source: Respiratory Research. 7/14/2020, Vol. 21 Issue 1, p1-12. 12p. 2 Charts, 5 Graphs.

Heme metabolism genes Downregulated in COPD Cachexia.

Authors: Wilson, Ava C. Kumar, Preeti L. Lee, Sool et al.

Source: Respiratory Research. 5/1/2020, Vol. 21 Issue 1, p1-9. 9p. 1 Diagram, 4 Charts, 1 Graph.

Blood gene expression risk profiles and interstitial lung abnormalities: COPDGene and ECLIPSE cohort studies.

Authors: Moll, Matthew Hobbs, Brian D. Menon, Aravind et al.

Source: Respiratory Research. 6/17/2022, Vol. 23 Issue 1, p1-13. 13p.

Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional study.

Authors: Sims, Michael W. Tal-Singer, Ruth M. Kierstein, Sonja et al.

Source: Respiratory Research. 2008, Vol. 9, Special section p1-9. 9p. 3 Charts, 2 Graphs.

The COPD Biomarker Qualification Consortium (CBQC).

Authors: Casaburi, Richard Celli, Bartolome Crapo, James et al.

Source: COPD: Journal of Chronic Obstructive Pulmonary Disease. Jun2013, Vol. 10 Issue 3, p367-377. 11p. 1 Diagram, 2 Charts, 1 Graph.

Blood neutrophil counts are associated with exacerbation frequency and mortality in COPD.

Authors: Lonergan, Mike Dicker, Alison J. Crichton, Megan L. et al.

Source: Respiratory Research. 7/1/2020, Vol. 21 Issue 1, p1-10. 10p. 1 Diagram, 1 Chart, 3 Graphs.

Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study.

Authors: Fermont, Jilles M. Bolton, Charlotte E. Fisk, Marie et al.

Source: PLoS ONE. 2/10/2020, Vol. 15 Issue 2, p1-16. 16p.

Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease: A Large Case-Controlled Study.

Authors: Fisk, Marie Mceniery, Carmel M. Gale, Nichola et al.

Source: Hypertension (0194911X). Mar2018, Vol. 71 Issue 3, p499-506.

Specific elastin degradation products are associated with poor outcome in the ECLIPSE COPD cohort.

Authors: Rønnow, Sarah Rank Langholm, Lasse Løcke Sand, Jannie Marie Bülow et al.

Source: Scientific Reports. 3/11/2019, Vol. 9 Issue 1, p1-13. 13p.

Evaluating the Role of Inflammation in Chronic Airways Disease: The ERICA Study.

Authors: Mohan, Divya Gale, Nichola S. McEniery, Carmel M. et al.

Source: COPD: Journal of Chronic Obstructive Pulmonary Disease. Sep2014, Vol. 11 Issue 5, p552-559. 8p.

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Inhaled Doses of Umeclidinium in Healthy Subjects: Two Randomized Studies.

Authors: Cahn, Anthony Tal-Singer, Ruth Pouliquen, Isabelle et al.

Source: Clinical Drug Investigation. 2013, Vol. 33 Issue 7, p477-488.

Quantitative analysis of dynamic F-FDG PET/CT for measurement of lung inflammation.

Authors: Coello, Christopher Fisk, Marie Mohan, Divya et al.

Source: EJNMMI Research. 5/25/2017, Vol. 7 Issue 1, p1-12. 12p.

High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study.

Authors: Sand, Jannie M. B. Leeming, Diana J. Byrjalsen, Inger et al.

Source: Respiratory Research. 10/4/2016, Vol. 17, p1-12. 12p. 1 Diagram, 3 Charts, 3 Graphs.

Altered Gene Expression in Blood and Sputum in COPD Frequent Exacerbators in the ECLIPSE Cohort.

Authors: Singh, Dave Fox, Steven M. Tal-Singer, Ruth et al.

Source: PLoS ONE. Sep2014, Vol. 9 Issue 9, p1-9. 9p.